TXG - 10x Genomics Q4 2022 Earnings Preview
- 10x Genomics ( NASDAQ: TXG ) is scheduled to announce Q4 earnings results on Wednesday, February 15th, after market close.
- The consensus EPS Estimate is -$0.20 (-25.0% Y/Y) and the consensus Revenue Estimate is $148.17M (+3.3% Y/Y).
- Over the last 1 year, TXG has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward.
For further details see:
10x Genomics Q4 2022 Earnings Preview